| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
28,142 |
26,437 |
$2.26M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13,918 |
13,116 |
$1.48M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
22,274 |
21,218 |
$1.33M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
15,523 |
14,734 |
$1.12M |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
9,442 |
8,679 |
$236K |
| 87428 |
|
4,371 |
4,214 |
$232K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
15,111 |
14,492 |
$211K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,915 |
2,816 |
$82K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
638 |
597 |
$21K |
| 81003 |
|
4,530 |
4,280 |
$8K |
| 81025 |
|
985 |
960 |
$7K |
| 99051 |
|
5,229 |
5,061 |
$5K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
77 |
69 |
$3K |
| 87807 |
|
206 |
198 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
100 |
95 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
144 |
134 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
19 |
18 |
$896.70 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
13 |
13 |
$507.52 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
13 |
13 |
$494.52 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
62 |
59 |
$303.49 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
114 |
113 |
$146.72 |
| 87070 |
|
13 |
12 |
$90.10 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
12 |
12 |
$13.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
14 |
14 |
$1.36 |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
9,481 |
9,127 |
$0.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
65 |
63 |
$0.00 |